Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Pamela H. Kempert, M.D.
Pamela H. Kempert, M.D.

Specialty:

Pediatric Hematology-Oncology

General Information:

Gender:
Female
Language(s):
English

Affiliation(s):

Associate Clinical Professor, Department of Pediatrics, Hematology/Oncology
Principal Investigator, UCLA Children’s Oncology Group
Member, JCCC Cancer and Stem Cell Biology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education:

Fellowship:
Pediatric Hematology Oncology, Children's Hospital of Orange County, 1982 - 1984
Pediatric Ambulatory, Children's Hospital of Orange County, 1980 - 1982
Residency:
Pediatrics, UC Irvine Medical Center, 1976 - 1982
Medical Degree:
M.D., Ohio State University College of Medicine, 1976

Certification(s):

Medical Board Certification(s):
Pediatric Hematology-Oncology, American Board of Pediatrics, 1987
Pediatrics, American Board of Pediatrics, 1983

Contact Information:

Phone:
(310) 825-6708
Email:

Practice Information:

Clinical Interest(s):
Acute lymphocytic leukemia
Hepatoblastoma
Lymphoma
Pediatric germ cell tumors
Pediatric hematology
Pediatric renal tumors
Post-transplant lymphoproliferative disorders

Scientific Interest(s):

Dr. Pamela Kempert’s scientific interest has been research into the clinical treatment of childhood cancer as the children's oncology group principal investigator.

Selected Cancer-Related Publications:

Presson A, Moore TB, Kempert P. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis. J Pediatr Hematol Oncol. 2010 Aug;32(6):454-61. doi: 10.1097/MPH.0b013e3181e001c2.

Seth T, Kempert P. Embryonal rhabdomyosarcoma of lower lip. Indian Pediatr. 2004 Aug;41(8):858-9.

Neudorf S, Nourani A, Kempert P, Shen V, Sender L, Kirov I. Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML). Bone Marrow Transplant. 2004 May;33(10):1069.

Cairo MS, Mallett C, VandeVen C, Kempert P, Bennetts GA, Katz J. Impaired in vitro polymorphonuclear function secondary to the chemotherapeutic effects of vincristine, adriamycin, cyclophosphamide, and actinomycin D. J Clin Oncol. 1986 May;4(5):798-804.

Hodder FS, Kempert P, McCormack S, Bennetts GA, Katz J, Cairo MS. Immune thrombocytopenia following actinomycin-D therapy. J Pediatr. 1985 Oct;107(4):611-4.